Probing Allosteric Kinase Modulators as Next Game-Changers in Fighting Neurodegeneration.

Area of Science:

• Medicinal Chemistry
• Neuroscience
• Pharmacology

Background:

• Kinases are crucial targets in cancer therapy, with inhibitors achieving significant clinical success.
• Despite known roles in neurodegeneration, kinase-targeted therapies have lagged in treating these conditions.
• Allosteric kinase modulators offer a promising strategy to overcome selectivity challenges.

Purpose of the Study:

• To highlight the therapeutic potential of allosteric kinase modulators for neurodegenerative diseases.
• To showcase existing CNS-directed allosteric kinase modulators and their neuroprotective properties.
• To identify additional kinases and modulators for neuroprotection.

Main Methods:

• Review of developmental processes and neuroprotective properties of CNS-directed allosteric kinase modulators.
• Identification and discussion of kinases relevant to neuroprotection with validated allosteric modulators.
• Critical analysis of current drawbacks and future research directions.

Main Results:

• Allosteric kinase modulators have demonstrated neuroprotective effects.
• Several kinases relevant to neuroprotection have validated allosteric modulators not yet exploited.
• The development of these modulators faces specific challenges.

Conclusions:

• Allosteric kinase modulators represent a promising therapeutic avenue for neurodegenerative diseases.
• Further research and development are needed to translate this potential into clinical treatments.
• Exploiting novel kinase targets and overcoming existing challenges are key for future success.